Fate Therapeutics Inc (FATE) - Financial and Strategic SWOT Analysis Review

April 2021 | 51 pages | ID: F3E00750BC0EN
GlobalData

Abstracts

Fate Therapeutics Inc (FATE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – Analyst’s summarization of the company’s business strategy.
• SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
• Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
• Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Fate Therapeutics Inc (Fate Therapeutics) is a biopharmaceutical company that develops programmed cellular therapies for cancer and immune disorders. The company’s pipeline includes various Off-the-shelf, iPSC-derived cellular immunotherapies for the treatment of several Hematologic Malignancies and advanced solid tumors. Its pipeline also include donor-derived cell product candidate for the treatment of Hematologic Malignancies. Fate uses its proprietary human induced pluripotent stem cells (iPSCs) platform for the product development. The company also has research collaborations with companies, academic and medical centers for the advancements of products and technologies. Fate Therapeutics is headquarterd in San Diego, California, the US.

Fate Therapeutics Inc Key Recent Developments

Mar 25,2021: Fate Therapeutics Announces Retirement of Chief Scientific Officer after 12 Years of Service
Mar 08,2021: Fate Therapeutics to Present at Upcoming Investor Conferences
Feb 24,2021: Fate Therapeutics reports fourth quarter 2020 financial results and highlights operational progress
Feb 22,2021: Fate Therapeutics to Present at the 10th Annual SVB Leerink Global Healthcare Conference
Feb 19,2021: Fate Therapeutics to Webcast Conference Call Reporting Fourth Quarter and Full Year 2020 Financial Results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

• The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

• The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

• Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.

• Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

• Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Contents

SECTION 1 - ABOUT THE COMPANY

Fate Therapeutics Inc - Key Facts
Fate Therapeutics Inc - Key Employees
Fate Therapeutics Inc - Key Employee Biographies
Fate Therapeutics Inc - Major Products and Services
Fate Therapeutics Inc - History
Fate Therapeutics Inc - Company Statement
Fate Therapeutics Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Company Overview
Fate Therapeutics Inc - Business Description
Fate Therapeutics Inc - Corporate Strategy
Fate Therapeutics Inc - SWOT Analysis
SWOT Analysis - Overview
Fate Therapeutics Inc - Strengths
Fate Therapeutics Inc - Weaknesses
Fate Therapeutics Inc - Opportunities
Fate Therapeutics Inc - Threats
Fate Therapeutics Inc - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Fate Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Fate Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Fate Therapeutics Inc, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Mar 25, 2021: Fate Therapeutics Announces Retirement of Chief Scientific Officer after 12 Years of Service
Mar 08, 2021: Fate Therapeutics to Present at Upcoming Investor Conferences
Feb 24, 2021: Fate Therapeutics reports fourth quarter 2020 financial results and highlights operational progress
Feb 22, 2021: Fate Therapeutics to Present at the 10th Annual SVB Leerink Global Healthcare Conference
Feb 19, 2021: Fate Therapeutics to Webcast Conference Call Reporting Fourth Quarter and Full Year 2020 Financial Results
Nov 05, 2020: Fate Therapeutics announces twelve presentations at the 2020 ASH Annual Meeting
Nov 05, 2020: Fate Therapeutics reports third quarter 2020 financial results and highlights operational progress
Aug 19, 2020: Fate Therapeutics appoints Edward Dulac as Chief Financial Officer
Aug 05, 2020: Fate Therapeutics reports second quarter 2020 financial results and highlights operational progress
May 11, 2020: Fate Therapeutics reports first quarter 2020 financial results and highlights operational progress

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List Of Tables

LIST OF TABLES

Fate Therapeutics Inc, Key Facts
Fate Therapeutics Inc, Key Employees
Fate Therapeutics Inc, Key Employee Biographies
Fate Therapeutics Inc, Major Products and Services
Fate Therapeutics Inc, History
Fate Therapeutics Inc, Subsidiaries
Fate Therapeutics Inc, Key Competitors
Fate Therapeutics Inc, Ratios based on current share price
Fate Therapeutics Inc, Annual Ratios
Fate Therapeutics Inc, Annual Ratios (Cont...1)
Fate Therapeutics Inc, Interim Ratios
Fate Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Fate Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Fate Therapeutics Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List Of Figures

LIST OF FIGURES

Fate Therapeutics Inc, Performance Chart (2016 - 2020)
Fate Therapeutics Inc, Ratio Charts
Fate Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Fate Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021